TW200611686A - Effervescent oral opiate dosage forms and methods of administering opiates - Google Patents

Effervescent oral opiate dosage forms and methods of administering opiates

Info

Publication number
TW200611686A
TW200611686A TW094107151A TW94107151A TW200611686A TW 200611686 A TW200611686 A TW 200611686A TW 094107151 A TW094107151 A TW 094107151A TW 94107151 A TW94107151 A TW 94107151A TW 200611686 A TW200611686 A TW 200611686A
Authority
TW
Taiwan
Prior art keywords
dosage forms
opiates
methods
administering
effervescent oral
Prior art date
Application number
TW094107151A
Other languages
Chinese (zh)
Other versions
TWI354551B (en
Inventor
Derek Moe
Original Assignee
Cima Labs Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=46727947&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TW200611686(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US11/026,759 external-priority patent/US7862833B2/en
Application filed by Cima Labs Inc filed Critical Cima Labs Inc
Publication of TW200611686A publication Critical patent/TW200611686A/en
Application granted granted Critical
Publication of TWI354551B publication Critical patent/TWI354551B/en

Links

Classifications

    • Y02W90/11—

Abstract

Opiate containing dosage forms and methods using same are described. These dosage forms include substantially less opiates by weight than known oral formulations. These dosage forms are intended for oral administration across the oral mucosa.
TW94107151A 2004-10-04 2005-03-09 Effervescent oral opiate dosage forms and uses the TWI354551B (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US61578504P 2004-10-04 2004-10-04
US61566504P 2004-10-04 2004-10-04
US11/026,759 US7862833B2 (en) 2003-12-31 2004-12-30 Effervescent oral opiate dosage forms and methods of administering opiates

Publications (2)

Publication Number Publication Date
TW200611686A true TW200611686A (en) 2006-04-16
TWI354551B TWI354551B (en) 2011-12-21

Family

ID=46727947

Family Applications (1)

Application Number Title Priority Date Filing Date
TW94107151A TWI354551B (en) 2004-10-04 2005-03-09 Effervescent oral opiate dosage forms and uses the

Country Status (1)

Country Link
TW (1) TWI354551B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8802130B2 (en) 1998-03-27 2014-08-12 Cephalon, Inc. Sublingual buccal effervescent

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8802130B2 (en) 1998-03-27 2014-08-12 Cephalon, Inc. Sublingual buccal effervescent

Also Published As

Publication number Publication date
TWI354551B (en) 2011-12-21

Similar Documents

Publication Publication Date Title
EP1708685A4 (en) Effervescent oral opiate dosage forms and methods of administering opiates
IL176449A0 (en) Generally linear effervescent oral fentanyl dosage form and methods of administering
WO2005065317A3 (en) Effervescent oral fentanyl dosage form
WO2008085765A3 (en) Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain
NO20062504L (en) Compositions and dosage forms for improved absorption
WO2008131056A3 (en) Sustained release monoeximic formulations of opioid and nonopioid analgesics
TW200806318A (en) Uses of anti-insulin-like growth factor I receptor antibodies
SI1730147T1 (en) SUBSTITUTED 1,4,8-TRIAZASPIRO?á4,5?åDECAN-2-ON COMPOUNDS FOR USE IN THE TREATMENT OF OBESITY
WO2008131057A3 (en) Sustained release formulations of opioid and nonopioid analgesics
SI1730144T1 (en) Substituted 1,4,8-triazaspiro 4.5 decan-2-one compounds
HRP20041092A2 (en) New pharmaceutical compositions containing filbanserin polymorph a
TW200509992A (en) Dosage form containing pantoprazole as active ingredient
TW200611697A (en) Generally linear effervescent oral fentanyl dosage form and methods of administering
TW200503785A (en) Dosage form containing (S)-pantoprazole as active ingredient
TW200611686A (en) Effervescent oral opiate dosage forms and methods of administering opiates
TW200611696A (en) Effervescent oral fentanyl dosage form and methods of administering fentanyl
WO2005051489A3 (en) Fast dissolving solid oral dosage forms of galanthamine
UA101370C2 (en) Normal;heading 1;heading 2;heading 3;ORAL FORMULATIONS OF CYTIDINE ANALOGS AND METHODS OF USE THEREOF